ApplyBlast uses AI to match you with the right jobs, tailor your resume and cover letter, and apply automatically so you can land your dream job faster.

Features

Auto Apply Resume Optimizer Cover Letter Optimizer Interview Prep

Company

Social Media

Need Help?

team@applyblast.com

Technical Lead and Subject Matter Expert for Combination Products and Drug Delivery Devices at Scholar Rock - ApplyBlast

Technical Lead and Subject Matter Expert for Combination Products and Drug Delivery Devices

Scholar Rock

1 month ago

3.7 on Glassdoor

Cambridge, Massachusetts, United States

Hybrid

Full Time

Senior

0 applicants

View Job Listing

Apply to 100+ jobs

About this role

Scholar Rock is seeking a technical lead to provide hands-on leadership for combination product and drug delivery device development programs. The role involves leading device engineering activities, defining user requirements, and managing design controls for prefilled syringes and autoinjectors. This position requires collaboration with regulatory affairs and external partners to ensure successful product lifecycle management.

Responsibilities

Lead device engineering activities for prefilled syringe and autoinjector development programs
Provide technical leadership for drug-device integration and primary container interfaces
Define and maintain design history files and regulatory documentation for combination products

Skills

Qualifications

Bachelor's degree in Engineering, Life Sciences, or a related discipline

About Scholar Rock

scholarrock.com

Headquarters

Cambridge, Massachusetts, United States

Company Size

51-200 employees

Founded

2012

View Profile

Scholar Rock is a biopharmaceutical company focused on the discovery and development of innovative medicines. Using cutting‑edge science and translational research, it advances novel therapeutic candidates from discovery into clinical development to address serious unmet medical needs. The company’s mission is to discover, develop, and deliver therapies that improve people’s lives, combining bold scientific approaches with a patient‑focused commitment.